Atea Total Assets vs Accounts Payable Analysis

AVIR Stock  USD 3.30  0.10  2.94%   
Atea Pharmaceuticals financial indicator trend analysis is way more than just evaluating Atea Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Atea Pharmaceuticals is a good investment. Please check the relationship between Atea Pharmaceuticals Total Assets and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Atea Stock, please use our How to Invest in Atea Pharmaceuticals guide.

Total Assets vs Accounts Payable

Total Assets vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Atea Pharmaceuticals Total Assets account and Accounts Payable. At this time, the significance of the direction appears to have strong relationship.
The correlation between Atea Pharmaceuticals' Total Assets and Accounts Payable is 0.69. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Atea Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Atea Pharmaceuticals' Total Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Atea Pharmaceuticals are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Assets i.e., Atea Pharmaceuticals' Total Assets and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.69
Relationship DirectionPositive 
Relationship StrengthSignificant

Total Assets

Total assets refers to the total amount of Atea Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Atea Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Accounts Payable

An accounting item on the balance sheet that represents Atea Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Atea Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Atea Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Atea Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Atea Stock, please use our How to Invest in Atea Pharmaceuticals guide.As of 11/27/2024, Selling General Administrative is likely to drop to about 31.8 M. In addition to that, Tax Provision is likely to drop to about 967.1 K
 2021 2022 2023 2024 (projected)
Interest Income213K11.2M29.2M30.7M
Net Interest Income213K11.2M29.2M30.7M

Atea Pharmaceuticals fundamental ratios Correlations

0.820.690.980.730.960.550.52-0.89-0.240.690.890.580.570.41.00.970.85-0.980.990.950.390.980.571.00.97
0.820.320.870.830.870.390.1-0.69-0.050.910.690.430.430.240.830.830.76-0.820.850.650.010.870.420.820.84
0.690.320.530.060.50.010.97-0.72-0.110.010.720.010.02-0.040.690.560.48-0.610.610.850.940.530.010.690.56
0.980.870.530.840.990.640.34-0.85-0.240.80.840.670.660.490.980.980.86-0.981.00.880.21.00.650.980.99
0.730.830.060.840.840.8-0.17-0.46-0.430.930.450.830.840.40.730.790.76-0.820.790.55-0.290.840.830.730.83
0.960.870.50.990.840.660.32-0.79-0.30.840.790.680.680.440.960.990.85-0.970.980.870.170.990.670.960.99
0.550.390.010.640.80.66-0.13-0.25-0.690.610.251.00.990.540.550.640.59-0.670.60.47-0.280.641.00.550.68
0.520.10.970.34-0.170.32-0.13-0.62-0.03-0.210.61-0.14-0.13-0.080.520.390.3-0.430.430.730.980.34-0.140.520.37
-0.89-0.69-0.72-0.85-0.46-0.79-0.25-0.62-0.19-0.46-1.0-0.28-0.24-0.54-0.89-0.81-0.690.81-0.87-0.85-0.5-0.85-0.24-0.89-0.79
-0.24-0.05-0.11-0.24-0.43-0.3-0.69-0.03-0.19-0.240.19-0.68-0.740.19-0.23-0.32-0.340.38-0.24-0.330.01-0.24-0.72-0.24-0.37
0.690.910.010.80.930.840.61-0.21-0.46-0.240.460.650.650.330.690.790.71-0.730.750.47-0.330.80.640.690.79
0.890.690.720.840.450.790.250.61-1.00.190.460.270.230.540.890.810.68-0.80.870.850.50.840.240.890.79
0.580.430.010.670.830.681.0-0.14-0.28-0.680.650.270.990.540.570.660.62-0.690.630.48-0.280.671.00.570.7
0.570.430.020.660.840.680.99-0.13-0.24-0.740.650.230.990.450.560.660.6-0.690.620.49-0.270.661.00.570.7
0.40.24-0.040.490.40.440.54-0.08-0.540.190.330.540.540.450.40.430.35-0.380.450.26-0.230.490.480.40.41
1.00.830.690.980.730.960.550.52-0.89-0.230.690.890.570.560.40.960.85-0.980.990.950.390.980.561.00.97
0.970.830.560.980.790.990.640.39-0.81-0.320.790.810.660.660.430.960.84-0.970.980.90.230.980.650.961.0
0.850.760.480.860.760.850.590.3-0.69-0.340.710.680.620.60.350.850.84-0.870.870.780.190.860.610.850.86
-0.98-0.82-0.61-0.98-0.82-0.97-0.67-0.430.810.38-0.73-0.8-0.69-0.69-0.38-0.98-0.97-0.87-0.99-0.93-0.3-0.98-0.68-0.98-0.98
0.990.850.611.00.790.980.60.43-0.87-0.240.750.870.630.620.450.990.980.87-0.990.920.31.00.610.990.98
0.950.650.850.880.550.870.470.73-0.85-0.330.470.850.480.490.260.950.90.78-0.930.920.620.880.480.950.9
0.390.010.940.2-0.290.17-0.280.98-0.50.01-0.330.5-0.28-0.27-0.230.390.230.19-0.30.30.620.2-0.270.390.23
0.980.870.531.00.840.990.640.34-0.85-0.240.80.840.670.660.490.980.980.86-0.981.00.880.20.650.980.99
0.570.420.010.650.830.671.0-0.14-0.24-0.720.640.241.01.00.480.560.650.61-0.680.610.48-0.270.650.560.69
1.00.820.690.980.730.960.550.52-0.89-0.240.690.890.570.570.41.00.960.85-0.980.990.950.390.980.560.97
0.970.840.560.990.830.990.680.37-0.79-0.370.790.790.70.70.410.971.00.86-0.980.980.90.230.990.690.97
Click cells to compare fundamentals

Atea Pharmaceuticals Account Relationship Matchups

Atea Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets22.1M863.6M772.9M666.7M595.0M541.8M
Other Current Liab1.9M14.4M49.6M14.4M27.4M20.0M
Total Current Liabilities2.4M315.8M56.9M18.5M32.4M57.0M
Total Stockholder Equity(49.6M)547.8M710.1M640.6M555.2M434.1M
Other Liab95K36K5.9M5.3M6.0M6.3M
Net Tangible Assets(49.6M)547.8M710.1M640.6M736.7M398.8M
Property Plant And Equipment Net41K48K23K4.1M3.1M3.3M
Net Debt(21.7M)(850.1M)(764.2M)(643.6M)(141.4M)(148.5M)
Retained Earnings(54.2M)(65.2M)56.0M(59.9M)(195.8M)(186.0M)
Accounts Payable548K60K4.5M2.6M4.3M2.3M
Cash21.7M850.1M764.4M646.7M143.8M136.6M
Cash And Short Term Investments21.7M850.1M764.4M646.7M578.1M530.8M
Common Stock Shares Outstanding82.6M82.4M88.2M83.2M83.4M85.7M
Liabilities And Stockholders Equity22.1M863.6M772.9M666.7M595.0M541.8M
Non Current Liabilities Total69.2M36K5.9M7.7M7.4M7.0M
Other Current Assets249K15.1M16.1M14.2M12.3M10.7M
Other Stockholder Equity4.6M1.5B654.0M701.1M750.7M658.3M
Total Liab71.6M315.8M62.8M26.1M39.8M78.3M
Net Invested Capital(49.6M)547.8M710.1M640.6M555.2M434.1M
Property Plant And Equipment Gross41K48K184K4.4M3.8M4.0M
Total Current Assets21.9M863.5M772.4M660.9M590.5M539.7M
Net Working Capital19.5M547.7M715.5M642.4M558.1M461.3M
Property Plant Equipment41K48K23K4.1M4.7M4.9M

Pair Trading with Atea Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Atea Stock

  0.68VALN Valneva SE ADRPairCorr
  0.77FDMT 4D Molecular TherapeuticsPairCorr
  0.76JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.68LLY Eli Lilly Sell-off TrendPairCorr

Moving against Atea Stock

  0.72BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.59GILD Gilead SciencesPairCorr
  0.53NAMS NewAmsterdam PharmaPairCorr
  0.44LPCN LipocinePairCorr
  0.43MNOV MediciNovaPairCorr
The ability to find closely correlated positions to Atea Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea Pharmaceuticals to buy it.
The correlation of Atea Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Atea Stock Analysis

When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.